World's Best Scientists 2026 revealed!
VIEW LIST
Viviana Galimberti

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 94 10389 9752 371 355 386 37293

Viviana Galimberti publications per year

The chart shows the history of publications by Viviana Galimberti between 1987 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Viviana Galimberti published across 39 years, from 1987 to 2025, averaging 10.6 papers a year. Output peaked at 28 publications in 2021. 24 of the 412 publications appeared in the last two years.

No. of publications
5 10 15 20 25
Bar chart. Horizontal axis: year, 1987 to 2025. Vertical axis: number of publications, 0 to 28. Peak 28 publications in 2021. 1987: 1 publication 1988: 0 publications 1989: 1 publication 1990: 3 publications 1991: 2 publications 1992: 4 publications 1993: 11 publications 1994: 6 publications 1995: 0 publications 1996: 4 publications 1997: 8 publications 1998: 7 publications 1999: 8 publications 2000: 3 publications 2001: 7 publications 2002: 12 publications 2003: 5 publications 2004: 11 publications 2005: 14 publications 2006: 14 publications 2007: 11 publications 2008: 12 publications 2009: 19 publications 2010: 14 publications 2011: 13 publications 2012: 6 publications 2013: 10 publications 2014: 7 publications 2015: 7 publications 2016: 15 publications 2017: 23 publications 2018: 24 publications 2019: 21 publications 2020: 23 publications 2021: 28 publications 2022: 13 publications 2023: 21 publications 2024: 17 publications 2025: 7 publications
1987 2025

412 publications in total across all disciplines

View publications per year as a table
Viviana Galimberti: publications per year, 1987 to 2025
Year Publications
1987 1
1988 0
1989 1
1990 3
1991 2
1992 4
1993 11
1994 6
1995 0
1996 4
1997 8
1998 7
1999 8
2000 3
2001 7
2002 12
2003 5
2004 11
2005 14
2006 14
2007 11
2008 12
2009 19
2010 14
2011 13
2012 6
2013 10
2014 7
2015 7
2016 15
2017 23
2018 24
2019 21
2020 23
2021 28
2022 13
2023 21
2024 17
2025 7
Total 412
Download as CSV

Viviana Galimberti publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Viviana Galimberti sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 381–400 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 386 publications — 35th percentile

35% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861 386
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Viviana Galimberti D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Viviana Galimberti sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 94–95 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 94 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808 94
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Viviana Galimberti is affiliated with the European Institute of Oncology in Italy and has an extensive research portfolio focused mainly on breast cancer treatment and related oncology fields. Their scholarly contributions span multiple high-impact journals and involve collaboration with several frequently co-authoring researchers.

Galimberti's recent publications include the following papers:

  • Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021 (2021, Annals of Oncology)
  • Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes (2023, JAMA Oncology)
  • Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial (2021, The Lancet Oncology)
  • Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up (2020, European Journal of Surgical Oncology)
  • Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14,324 women in 16 trials (2023, The Lancet)

The researcher frequently collaborates with colleagues including Paolo Veronesi, Maria Cristina Leonardi, Giovanni Corso, Francesca Magnoni, and Roberto Orecchia.

Galimberti has contributed extensively to several publication venues, notably:

  • Radiotherapy and Oncology
  • European Journal of Surgical Oncology
  • Cancer Research
  • Breast Cancer Research and Treatment
  • Annals of Surgical Oncology

Their main fields of study are Medicine and Biochemistry, Genetics and Molecular Biology, reflecting a multifaceted scientific approach.

The subfields of study predominantly covered include:

  • Cancer Research
  • Oncology
  • Pathology and Forensic Medicine
  • Surgery
  • Molecular Biology

The primary topics of scientific work encompass:

  • Breast Cancer Treatment Studies
  • Breast Lesions and Carcinomas
  • Breast Implant and Reconstruction
  • Advanced Radiotherapy Techniques
  • Cancer Genomics and Diagnostics
  • Cancer Risks and Factors
  • Global Cancer Incidence and Screening

Best Publications

  • A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer.

    Umberto Veronesi;Giovanni Paganelli;Giuseppe Viale;Alberto Luini

  • Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.

    Umberto Veronesi;Giovanni Paganelli;Viviana Galimberti;Giuseppe Viale

  • Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial

    Viviana Galimberti;Bernard F. Cole;Bernard F. Cole;Stefano Zurrida;Giuseppe Viale;Giuseppe Viale

  • De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

    G. Curigliano;H. J. Burstein;E. P. Winer;M. Gnant

  • Radiotherapy after Breast-Preserving Surgery in Women with Localized Cancer of the Breast

    Umberto Veronesi;Alberto Luini;Marcella Del Vecchio;Marco Greco

  • Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series.

    U Veronesi;G Paganelli;G Viale;V Galimberti

  • Radiotherapy after breast-conserving surgery in small breast carcinoma: Long-term results of a randomized trial

    U. Veronesi;E. Marubini;L. Mariani;V. Galimberti

  • Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial

    Umberto Veronesi;Roberto Orecchia;Roberto Orecchia;Patrick Maisonneuve;Giuseppe Viale;Giuseppe Viale

  • Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study.

    Umberto Veronesi;Giuseppe Viale;Giovanni Paganelli;Stefano Zurrida

  • Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis.

    Salvatore Pece;Michela Serresi;Elisa Santolini;Maria Capra

  • Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study

    Umberto Veronesi;Giovanni Paganelli;Giuseppe Viale;Giuseppe Viale;Alberto Luini;Alberto Luini

  • Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021.

    H J Burstein;G Curigliano;B Thürlimann;W P Weber

  • Very young women (<35 years) with operable breast cancer: features of disease at presentation

    M. Colleoni;N. Rotmensz;C. Robertson;L. Orlando

  • Use of technetium-99m-labeled colloid albumin for preoperative and intraoperative localization of nonpalpable breast lesions

    Roberto Gennari;Viviana Galimberti;Concetta De Cicco;Stefano Zurrida

  • Quadrantectomy versus lumpectomy for small size breast cancer.

    Umberto Veronesi;Fabio Volterrani;Alberto Luini;Roberto Saccozzi

  • Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.

    Viviana Galimberti;Bernard F Cole;Giuseppe Viale;Giuseppe Viale;Paolo Veronesi;Paolo Veronesi

  • NUMB controls p53 tumour suppressor activity

    Ivan N. Colaluca;Daniela Tosoni;Paolo Nuciforo;Francesca Senic-Matuglia

  • Chemotherapy Is More Effective in Patients with Breast Cancer Not Expressing Steroid Hormone Receptors: A Study of Preoperative Treatment

    Marco Colleoni;Giuseppe Viale;David Zahrieh;Giancarlo Pruneri

  • Correction to: De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28(8) (1700–1712), (S0923753419321817), (10.1093/annonc/mdx308))

    G. Curigliano;H. J. Burstein;E. P. Winer;M. Gnant

  • Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes

    U. Veronesi;G. Paganelli;V. Galimberti;G. Viale

Frequent Co-Authors

Paolo Veronesi
Paolo Veronesi European Institute of Oncology
Giuseppe Viale
Giuseppe Viale University of Milan
Umberto Veronesi
Umberto Veronesi European Institute of Oncology
Nicole Rotmensz
Nicole Rotmensz European Institute of Oncology
Roberto Orecchia
Roberto Orecchia European Institute of Oncology
Marco Colleoni
Marco Colleoni European Institute of Oncology
Giovanni Paganelli
Giovanni Paganelli Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
Vincenzo Bagnardi
Vincenzo Bagnardi University of Milano-Bicocca
Patrick Maisonneuve
Patrick Maisonneuve European Institute of Oncology
Giancarlo Pruneri
Giancarlo Pruneri University of Milan

External Links

Personal website of Viviana Galimberti

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those exploring a future in medicine but seeking flexible options, a variety of online degrees and alternative pathways can open doors to rewarding healthcare careers. Many students begin by looking for cheap rn to bsn programs to advance their nursing qualifications affordably. These programs are ideal for registered nurses wanting to earn a Bachelor of Science in Nursing (BSN) online without breaking the bank.

Prospective nurses from non-nursing backgrounds often research msn direct entry programs online, which offer an accelerated route to a Master of Science in Nursing. These programs make it possible to pivot into nursing—even if your undergraduate degree is in a completely different field.

If your goal is to start your journey quickly, you might want to consider the easiest nursing schools to get into. These schools offer accessible admissions while still providing rigorous preparation for licensure exams.

Alternatively, those interested in administrative roles may find that medical billing and coding schools that accept fafsa can create a fast track to a vital position in healthcare—often entirely online, and with the benefit of financial aid eligibility.

Best Scientists Citing Viviana Galimberti

Giuseppe Viale

Giuseppe Viale

University of Milan

Publications: 143

Paolo Veronesi

Paolo Veronesi

European Institute of Oncology

Publications: 125

Monica Morrow

Monica Morrow

Memorial Sloan Kettering Cancer Center

Publications: 102

Kelly K. Hunt

Kelly K. Hunt

The University of Texas MD Anderson Cancer Center

Publications: 85

Henry Mark Kuerer

Henry Mark Kuerer

The University of Texas MD Anderson Cancer Center

Publications: 83

Armando E. Giuliano

Armando E. Giuliano

Cedars-Sinai Medical Center

Publications: 82

Umberto Veronesi

Umberto Veronesi

European Institute of Oncology

Publications: 79

Roberto Orecchia

Roberto Orecchia

European Institute of Oncology

Publications: 76

Marco Colleoni

Marco Colleoni

European Institute of Oncology

Publications: 61

Giovanni Paganelli

Giovanni Paganelli

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Publications: 55

Emiel J. Th. Rutgers

Emiel J. Th. Rutgers

Antoni van Leeuwenhoek Hospital

Publications: 51

Aron Goldhirsch

Aron Goldhirsch

European Institute of Oncology

Publications: 51

Charles E. Cox

Charles E. Cox

University of South Florida

Publications: 49

Merrick I. Ross

Merrick I. Ross

The University of Texas MD Anderson Cancer Center

Publications: 45

Shinzaburo Noguchi

Shinzaburo Noguchi

Osaka University

Publications: 44

Frank A. Vicini

Frank A. Vicini

Beaumont Health

Publications: 43

Trending Scientists

Geraldo Tadeu dos Santos

Geraldo Tadeu dos Santos

State University of Maringa

Enrico Coen

Enrico Coen

John Innes Centre

Steven W. Kennerley

Steven W. Kennerley

University College London

Marcel J.W. Veldhuis

Marcel J.W. Veldhuis

Apollo Vredestein

Gerhard Sandmann

Gerhard Sandmann

Goethe University Frankfurt

Hae Young Chung

Hae Young Chung

Pusan National University

Dan Gazit

Dan Gazit

Cedars-Sinai Medical Center

Michelle Birkett

Michelle Birkett

Northwestern University

Sebastian Volz

Sebastian Volz

University of Tokyo

Amir Averbuch

Amir Averbuch

Tel Aviv University

Tanja Schultz

Tanja Schultz

University of Bremen

Steve W. Cui

Steve W. Cui

Agriculture and Agriculture-Food Canada

Ivan K. Chu

Ivan K. Chu

University of Hong Kong

Christophe Volkringer

Christophe Volkringer

Institut Universitaire de France

Israel Nowik

Israel Nowik

Hebrew University of Jerusalem

Matts Lindbladh

Matts Lindbladh

Swedish University of Agricultural Sciences

Related Medicine Rankings & Guides

2027 Medical Lab Tech Programs Online: Best Schools

2027 Medical Lab Tech Programs Online: Best Schools
2027 Best Nurse Practitioner Programs in Mississippi – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Mississippi – Accredited Schools Online & Campus
2027 Best Shortest Online Post-Master's FNP Certificate Programs

2027 Best Shortest Online Post-Master's FNP Certificate Programs
2027 Best Online Sonography Programs

2027 Best Online Sonography Programs
2027 Easiest LPN Programs to Get Into

2027 Easiest LPN Programs to Get Into
2027 Best Online Nurse Practitioner Degree Programs

2027 Best Online Nurse Practitioner Degree Programs
2027 Fastest Online RN to MSN (No ADN Required) Bridge Programs

2027 Fastest Online RN to MSN (No ADN Required) Bridge Programs
2027 Best Online Adult-Gerontology ACNP Graduate Certificate Programs

2027 Best Online Adult-Gerontology ACNP Graduate Certificate Programs
2027 Best Online Nursing Programs in Washington: Accredited RN to BSN Programs

2027 Best Online Nursing Programs in Washington: Accredited RN to BSN Programs
September 2027 Fast Track LPN Programs Online - 6, 9, 10, 11, 12 Month Programs

September 2027 Fast Track LPN Programs Online - 6, 9, 10, 11, 12 Month Programs
2027 Most Affordable CNA to RN Online Bridge Programs

2027 Most Affordable CNA to RN Online Bridge Programs
2027 Most Affordable Online MSN in Nurse Executive Leadership Programs

2027 Most Affordable Online MSN in Nurse Executive Leadership Programs
2027 Best Online Associate Science in Nursing (ASN) Programs

2027 Best Online Associate Science in Nursing (ASN) Programs
2027 Fastest Online BSN to MSN Bridge Programs

2027 Fastest Online BSN to MSN Bridge Programs
2027 Best Paramedic-to-RN Bridge Programs

2027 Best Paramedic-to-RN Bridge Programs
2027 Best Occupational Therapy Programs

2027 Best Occupational Therapy Programs
2027 Best Nursing Schools in Texas – Accredited ADN, BSN, MSN Programs

2027 Best Nursing Schools in Texas – Accredited ADN, BSN, MSN Programs
2027 Best Online BSN to FNP Programs

2027 Best Online BSN to FNP Programs
2027 Best Online Nursing Programs in California: Accredited RN to BSN Programs

2027 Best Online Nursing Programs in California: Accredited RN to BSN Programs
2027 Best Online Nursing Programs in Texas – Accredited RN to BSN Programs

2027 Best Online Nursing Programs in Texas – Accredited RN to BSN Programs
2027 Best One-Year Online PMHNP Programs

2027 Best One-Year Online PMHNP Programs

Recently Published Articles

2027 Are Too Many Students Choosing Sports Psychology? Oversaturation, Competition, and Hiring Reality

2027 Are Too Many Students Choosing Sports Psychology? Oversaturation, Competition, and Hiring Reality
2027 Can You Get Into a Construction Management Program with a Low GPA? Admission Chances & Workarounds

2027 Can You Get Into a Construction Management Program with a Low GPA? Admission Chances & Workarounds
2027 Is Walden University Worth It? Tuition, Value, and ROI

2027 Is Walden University Worth It? Tuition, Value, and ROI
2027 Fastest Online MSN in Nurse Executive Leadership Programs

2027 Fastest Online MSN in Nurse Executive Leadership Programs
2027 Fastest-Growing Careers for Bioinformatics Degree Graduates

2027 Fastest-Growing Careers for Bioinformatics Degree Graduates
2027 How to Become an Entrepreneur: Education, Salary, and Job Outlook

2027 How to Become an Entrepreneur: Education, Salary, and Job Outlook
2027 Highest Paying Jobs in IT and Technology

2027 Highest Paying Jobs in IT and Technology
2027 Best Online Master’s in Gerontology Programs

2027 Best Online Master’s in Gerontology Programs
2027 Most Affordable Online Bachelor's in Mathematics Degree Programs

2027 Most Affordable Online Bachelor's in Mathematics Degree Programs
2027 Is Demand for Criminal Justice Degree Graduates Growing or Declining?

2027 Is Demand for Criminal Justice Degree Graduates Growing or Declining?
2027 How to Become a BCBA in Vermont

2027 How to Become a BCBA in Vermont
2027 Remote Jobs You Can Get With an Organizational Leadership Master's Degree

2027 Remote Jobs You Can Get With an Organizational Leadership Master's Degree
2027 Hardest and Easiest Courses in an Architecture Degree Program

2027 Hardest and Easiest Courses in an Architecture Degree Program
2027 Cheapest Online Gerontology and Aging Master's Degrees That Pay Well: Tuition, Duration, and Earnings

2027 Cheapest Online Gerontology and Aging Master's Degrees That Pay Well: Tuition, Duration, and Earnings
2027 Is Walden University's Online MSN to PhD in Nursing - Healthcare Administration Worth It? What Students Should Know

2027 Is Walden University's Online MSN to PhD in Nursing - Healthcare Administration Worth It? What Students Should Know
2027 Cheapest Online Logistics Master's Degrees That Pay Well: Tuition, Duration, and Earnings

2027 Cheapest Online Logistics Master's Degrees That Pay Well: Tuition, Duration, and Earnings
2027 Cheapest and Shortest Online Reading & Literacy Degree Programs That Pay Well: Cost, Duration, and Salary Outlook

2027 Cheapest and Shortest Online Reading & Literacy Degree Programs That Pay Well: Cost, Duration, and Salary Outlook
2027 Is a Public Health Master's Degree Worth It? ROI, Salary & Career Impact

2027 Is a Public Health Master's Degree Worth It? ROI, Salary & Career Impact
2027 How to Become a Nurse Practitioner in South Carolina

2027 How to Become a Nurse Practitioner in South Carolina
2027 Speech Pathology Degree Careers Ranked by Salary, Growth, and Work-Life Balance

2027 Speech Pathology Degree Careers Ranked by Salary, Growth, and Work-Life Balance
2027 Fastest Way To Become a Counselor in Massachusetts

2027 Fastest Way To Become a Counselor in Massachusetts